. 2016 Dec 13;75:10.3402/ijch.v75.33804. doi: 10.3402/ijch.v75.33804

Table XVII.

Concentrations of selected contaminants across Arctic countries, compared with biomonitoring in non-Arctic areas

	USA^a	CAN^b	GRL^a^,^c	ISL^a	FRO^a	NOR^a	SWE	FIN	RUS	CHMS	NHANES
DDE	82.7	130^a	587	36	131	38.7	34^d^,^e	–	102^a	102^f	241^g
PCB 153	14.8	40^a	288	34	91.2	24.8	24^d^,^e	18.7^d	12.2^a	8.2^f	19.7^g
PBDE 47	19.8	<LOD^a	2.4	1.7	–	–	0.4^d^,^e	1.6^d^,^h	–	10.8^f	19.6^g
PBDE 99	4.5	<LOD	1.3	<1.3	–	–	–	1.6^d^,^h	–	N/Cⁱ	N/Cⁱ
PFOS	2.2	3.9^a	15.8	6.2	–	8.0^e	6.7^f	–	–	4.4^f	7.6^g
Hg	2.2	5.2^a	7.0	–	–	1.2	0.6^a^,^e	–	1.6^f	0.7^f	0.7^g
Pb	7.4	14^a	6.0	–	–	7.4	10^e^,^f	–	29.6^f	8.5^f	8.4^g
Se	181	300^a	140	–	–	84.7	–	–	–	190^f	188^g

Data presented as geometric means, in blood of pregnant women or WCBA, except for DDE and PCB153 in Sweden and Finland which are levels in breast milk. POPs presented in µg/kg plasma lipid and metals in µg/L whole blood. CHMS, Canadian Health Measures Survey; NHANES, US National Health and Nutrition Examination Survey.

Pregnant women;

Nunavik;

Eastern Greenland;

data are for breast milk from first-time mothers (g/kg lipid);

median value;

WCBA;

data for all females, ages 12+ years;

PBDE47 and PBDE99 results combined with other PBDEs;

ⁱ

geometric mean not calculated as proportion of results below detection limit was too high to provide a valid result.